Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRENE.L Regulatory News (RENE)

  • There is currently no data for RENE

Director/PDMR Shareholding

8 Aug 2007 16:58

ReNeuron Group plc08 August 2007 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. (3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24. (4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes in block capital letters. 1. Name of the issuer RENEURON GROUP PLC 2. State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) A TRANSACTION NOTIFIED IN ACCORDANCE WITH DR 3.1.4R(1)(A). 3. Name of person discharging managerial responsibilities/director JOHN SINDEN - DIRECTOR 4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person 5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest(1) 6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares 7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them 8. State the nature of the transaction 9. Number of shares, debentures or financial instruments relating to shares acquired 10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) 11. Number of shares, debentures or financial instruments relating to shares disposed 12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) 13. Price per share or value of transaction 14. Date and place of transaction 15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 16. Date issuer informed of transaction If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes 17. Date of grant 7 AUGUST 2007 18. Period during which or date on which it can be exercised 10 YEARS FROM THE 7 AUGUST 2007 SUBJECT TO PERFORMANCE CONDITIONS 19. Total amount paid (if any) for grant of the option NIL 20. Description of shares or debentures involved (class and number) 1,000,000 ORDINARY SHARES 21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise 500,000 ORDINARY SHARES AT AN EXERCISE PRICE OF 21 PENCE PER SHARE; AND 500,000 ORDINARY SHARES AT AN EXERCISE PRICE OF 37.5 PENCE PER SHARE. 22. Total number of shares or debentures over which options held following notification 3,396,680 ORDINARY SHARES (INCLUDING ALL PREVIOUS OPTIONS) 23. Any additional information GRANTED UNDER THE RULES OF THE EMPLOYEE SHARE OPTION SCHEME 24. Name of contact and telephone number for queries MICHAEL HUNT CHIEF EXECUTIVE OFFICER PH: +44(0) 1483302560 Name and signature of duly authorised officer of issuer responsible for making notification Date of notification 8/8/07 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th Apr 20137:00 amRNSPresentation on Mechanisms of Action
17th Apr 20134:40 pmRNSSecond Price Monitoring Extn
17th Apr 20134:35 pmRNSPrice Monitoring Extension
4th Apr 20134:40 pmRNSSecond Price Monitoring Extn
4th Apr 20134:35 pmRNSPrice Monitoring Extension
28th Mar 20137:02 amRNSCollaboration with Cell Therapy Catapult
27th Mar 20137:00 amRNSDosing Completed in Stroke Trial
26th Mar 20137:00 amRNSApprovals for Stem Cell Trial in CLI
19th Mar 20134:40 pmRNSSecond Price Monitoring Extn
19th Mar 20134:35 pmRNSPrice Monitoring Extension
11th Mar 20137:00 amRNSWins Two Biomedical Catalyst Grants
6th Mar 20134:35 pmRNSPrice Monitoring Extension
25th Feb 20137:00 amRNSAIM Rule 17 Notification
29th Jan 20137:00 amRNSStroke Trial Update: Final Cohort Begins Dosing
11th Jan 20134:40 pmRNSSecond Price Monitoring Extn
11th Jan 20134:35 pmRNSPrice Monitoring Extension
4th Dec 20127:01 amRNSReNeuron to Present at UK Stroke Forum
4th Dec 20127:00 amRNSInterim Results
22nd Nov 20127:00 amRNSNon-Clinical Data
21st Nov 20127:00 amRNSNotification of Interim Results
17th Oct 20127:00 amRNSFurther Progress with Stroke Trial
21st Sep 201212:39 pmRNSTR-1: Notification of Major Interest in Shares
14th Sep 201210:00 amRNSDirectors' Interest in Shares and Share Options
11th Sep 201210:38 amRNSResults of 2012 Annual General Meeting
11th Sep 20127:00 amRNSAGM Trading Update
14th Aug 20127:00 amRNSStroke Trial Update
7th Aug 20129:42 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
16th Jul 20127:00 amRNSPosting of Annual Report & Notice of AGM
5th Jul 20124:40 pmRNSSecond Price Monitoring Extn
5th Jul 20124:35 pmRNSPrice Monitoring Extension
28th Jun 20127:01 amRNSSSAG and Non-Executive Board Changes
28th Jun 20127:00 amRNSPreliminary Results
19th Jun 20127:00 amRNSNotification of Preliminary Results
15th Jun 20127:00 amRNSPresents Further Data
14th Jun 20127:00 amRNSPISCES Trial Interim Data
8th Jun 201210:13 amRNSNotice of Major Interest in Shares
21st May 20127:00 amRNSPresentation at World Stem Cells Congress
16th May 20127:00 amRNSCell Manufacturing Contract
11th May 201211:09 amRNSNotifications of Major Interests in Shares
8th May 201210:52 amRNSTR-1: Notification of Major Interest in Shares
3rd May 201212:21 pmRNSAdmission of Open Offer Shares
27th Apr 20123:37 pmRNSTR-1: Notification of Major Interest in Shares
27th Apr 20123:26 pmRNSTR-1: Notification of Major Interest in Shares
27th Apr 20127:00 amRNSResult of Placing and Open Offer
20th Apr 20122:54 pmRNSResult of General Meeting
20th Apr 20127:00 amRNSInvestor Conference
19th Apr 201210:16 amRNSNotification of Major Interest in Shares
3rd Apr 20127:00 amRNSPlacing and Open Offer
30th Mar 20127:00 amRNSIssue of Ordinary Shares
27th Mar 20127:00 amRNSExercise of Warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.